Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36622702

Longer versus Shorter Schedules of Vincristine, Irinotecan, and Temozolomide (VIT) for Relapsed or Refractory Ewing Sarcoma: A Randomized Controlled Phase 2 Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Clin Cancer Res
Publication date
2023 Mar 14
First author
Xu J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Xu J
      type
      Author
    2. name
      Xie L
      type
      Author
    3. name
      Sun X
      type
      Author
    4. name
      Liu K
      type
      Author
    5. name
      Liang X
      type
      Author
    6. name
      Cai Z
      type
      Author
    7. name
      Tang X
      type
      Author
    8. name
      Guo W
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Xu J
      type
      Author
    2. name
      Xie L
      type
      Author
    3. name
      Sun X
      type
      Author
    4. name
      Liu K
      type
      Author
    5. name
      Liang X
      type
      Author
    6. name
      Cai Z
      type
      Author
    7. name
      Tang X
      type
      Author
    8. name
      Guo W
      type
      Author
    bibliography ids
    1. nci-bib-a98e8d2ef524268f606d6b89
    book metadata
    content sha256
    7cc8b9a3b7d6f807112dbceee8a41d0ff633bdc1eb3084b1102e7769b479a5a6
    document type
    citation
    dois
    1. 10.1158/1078-0432.CCR-22-3546
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:36622702
    immutable id
    pubmed:36622702@7cc8b9a3b7d6f807112dbceee8a41d0ff633bdc1eb3084b1102e7769b479a5a6
    journal
    abbreviation
    Clin Cancer Res
    issn electronic
    1557-3265
    issn print
    1078-0432
    issue
    6
    name
    Clinical cancer research : an official journal of the American Association for Cancer Research
    nlm unique id
    9502500
    pages
    1040-1046
    volume
    29
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      36622702
      provenance
      batch id
      d370e99271168e8a8a13
      provider
      NCBI PubMed ESummary
      record sha256
      d8d908b123a598d305608082c4d4ab9ed7c9d46b85bf9e7905278e05f0778da6
      response sha256
      f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
      retrieved at
      2026-09-09T23:48:13.005737+00:00
      publication date
      display
      2023 Mar 14
      precision
      day
      year
      2023
      publication types
      1. Randomized Controlled Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/36622702/
      title
      Longer versus Shorter Schedules of Vincristine, Irinotecan, and Temozolomide (VIT) for Relapsed or Refractory Ewing Sarcoma: A Randomized Controlled Phase 2 Trial.

      Preserved source evidence · Not medical advice